Drug Metabolism Letters
Volume 15, 3 Issues, 2022
ISSN: 1874-0758 (Online)
ISSN: 1872-3128 (Print)
This journal supports open access
ISSN: 1874-0758 (Online)
ISSN: 1872-3128 (Print)
This journal supports open access
Most Cited Articles
Research Article
Comparison of rat and human pulmonary metabolism using precision-cut lung slices (PCLS)
, 2019; 13(1): 53-63.Yildiz Yilmaz*, Gareth Williams, Markus Walles, Nenad Manevski, Stephan Krähenbühl and Gian Camenisch
DOI: 10.2174/1872312812666181022114622
Research Article
Imatinib uptake into cells is not mediated by organic cation transporters OCT1, OCT2, or OCT3, but is influenced by extracellular pH
, 2019; 13(2): 102-110.Jaurès B. Mettral, Nicolas Faller, Sandra Cruchon, Loïc Sottas, Thierry Buclin, Laurent Schild, Eva Choong, Aimable Nahimana and Laurent A. Decosterd*
DOI: 10.2174/1872312813666190207150207
Research Article
“Branched tail” oxyquinoline inhibitors of HIF prolyl hydroxylase: Early evaluation of toxicity and metabolism using liver-on-a-chip
, 2019; 13(1): 45-52.Andrey A. Poloznikov*, Sergey V. Nikulin, Arpenik A. Zakhariants, Anna Y. Khristichenko, Dmitry M. Hushpulian, Ildar N. Gazizov, Vladimir I. Tishkov and Irina G. Gazaryan
DOI: 10.2174/1872312813666181129100950
Research Article
Formation of a toxic quinoneimine metabolite from diclofenac: A quantum chemical study
, 2019; 13(1): 64-76.Muthusamy Ramesh* and Prasad V. Bharatam
DOI: 10.2174/1872312812666180913120736
Review Article
Use of cocktail probe drugs for indexing cytochrome p450 enzymes in clinical pharmacology studies – Review of case studies
, 2019; 13(1): 3-18.Poonam Giri, Harilal Patel and Nuggehally R. Srinivas*
DOI: 10.2174/1872312812666181119154734
Research Article
Effect of aqueous extract of azadirachta indica leaves on pharmacokineics and pharmacodynamics of glipizide
, 2019; 13(1): 19-24.Sugandha Chaudhari*, Shitalkumar Zambad and Mohammed Ali
DOI: 10.2174/1872312812666181106115247
Research Article
Transport of bupropion and its metabolites by the model CHO and HEK293 cell lines
, 2019; 13(1): 25-36.Lyrialle W. Han, Chunying Gao, Yuchen Zhang, Joanne Wang and Qingcheng Mao*
DOI: 10.2174/1872312813666181129101507
Opinion Article
Assessment of herb-drug interactions based on the pharmacokinetic changes of probe drug, midazolam
, 2021; 14(1): 5-8.Sarvesh Sabarathinam* and Thangavel M. Vijayakumar*
DOI: 10.2174/1872312814666201112122110
Systematic Review Article
Major cyp450 polymorphism among saudi patients
, 2021; 14(1): 17-24.Ahmad A. Almeman*
DOI: 10.2174/1872312814666200722122232
Research Article
Assessment of inhibition of bovine hepatic cytochrome P450 by 43 commercial bovine medicines using a combination of in vitro assays and pharmacokinetic data from the literature
, 2019; 13(2): 123-131.Steven X. Hu*, Chase A. Mazur and Kenneth L. Feenstra
DOI: 10.2174/1872312813666191120094649
Review Article
A practical perspective on the evaluation of small molecule CNS penetration in drug discovery
, 2019; 13(2): 78-94.Liyue Huang*, Mary C. Wells and Zhiyang Zhao
DOI: 10.2174/1872312813666190311125652
Research Article
An effective qwba/uhplc-ms/tissue punch approach: Solving a pharmacokinetic issue via quantitative met-id
, July 2021; 14(2): 152-162.József Pánczél*, Manfred Schudok, Matthias Schiell, Jens Riedel and Vilmos Kertesz*
DOI: 10.2174/1872312814666210813114700
Letter Article
Pharmacokinetics of darolutamide, its diastereomers and active metabolite in the mouse: Response to saini nk et al. (2020)
, 2021; 14(1): 9-16.Pirjo Nykänen, Timo Korjamo, Hille Gieschen, Christian Zurth and Mikko Koskinen*
DOI: 10.2174/1872312814666201112121129
Opinion Article
A short exploration of selected sensitive cyp3a4 substrates (Probe drug)
, 2021; 14(1): 2-4.Sarvesh Sabarathinam and Thangavel M. Vijayakumar*
DOI: 10.2174/1872312814666200811110024
Research Article
Pharmacokinetics of darolutamide in mouse - assessment of the disposition of the diastereomers, key active metabolite and interconversion phenomenon: Implications to cancer patients
, 2021; 14(1): 54-65.Neeraj K. Saini, Bhavesh B. Gabani, Umesh Todmal, Suresh P. Sulochana, Vinay Kiran, Mohd. Zainuddin, Narayanan Balaji, Sai B. Polina, Nuggehally R. Srinivas and Ramesh Mullangi*
DOI: 10.2174/1872312814666200521091236
Editor-in-Chief
Zhiyang Zhao
Alliance Pharma
Malvern, PA
(USA)
Biography
Alliance Pharma
Malvern, PA
Biography
Biography of Zhiyang Zhao
Zhiyang Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Tech, Blacksburg, Virginia, USA. Dr. Zhao’s biopharmaceutical/pharmaceutical work experience encompasses over 25 years of research in metabolic and pharmacokinetic properties of compounds for drug discovery and development at Pfizer, GlaxoSmithKline and Amgen. Currently, Dr. Zhao serves as Chief Scientific Officer (CSO) at Alliance Pharma, Inc. and is appointed as an adjunct professor at the School of Pharmacy, the University of North Carolina at Chapel Hill. Dr. Zhao has published over 50 peer-reviewed original research papers and patents in the areas of new drug targets, drug metabolism, pharmacokinetics, and toxicology.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Drug Metabolism Letters was launched in 2007. Dr. Zhiyang Zhao serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net